Company / Return on Equity (ROE)
Vanda Pharmaceuticals Inc. Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
0.5%
FY2025
5-year range
0.5% / 28.1%
FY2021-FY2025
Trend
-60.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -30.0% in FY2017 to 28.1% in FY2021.
Based on SEC 10-K filings.
0.5% in FY2025 with a 5-year CAGR of -8.7%.
Declined from 6.6% to 0.5% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -4.7pp
- 5-Year Change
- -8.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 60.5% year-over-year.
- Peak return on equity (roe) was recorded in FY2021.
- Lowest return on equity (roe) in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -3.96 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 0.5% | -60.5% |
| FY2024 | 1.2% | -81.9% |
| FY2023 | 6.6% | +27.6% |
| FY2022 | 5.1% | -81.7% |
| FY2021 | 28.1% | +207.3% |
| FY2020 | 9.2% | +177.2% |
| FY2019 | -11.8% | +13.6% |
| FY2018 | -13.7% | +54.3% |
| FY2017 | -30.0% | -338.8% |
| FY2016 | 12.6% | +126.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026